Inhibition of the KCa3.1 channels has been reported to suppress proliferation of prostate cancer cells (45, 46, 47) and to suppress migration in glioblastoma cells (9, 14, 48, 49). This evidence concerns the gene KCNN4 and prostate carcinoma.